美股市場個股詳情

ENOV Enovis Corp

添加自選

55.400
+0.170+0.31%

收盤價 05/01 16:00 (美東)

55.400
0.0000.00%

盤後 16:20 (美東)

30.38億總市值-90819市盈率TTM

Enovis Corp股票討論區

登錄發表評論

Moomoo AI

02/26 21:55

The company's use of debt is seen as risky due to its EBIT loss and the liabilities it has. The balance sheet is not considered strong, but it could improve over time. The stock is considered quite risky.

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

Moomoo AI

02/26 07:55

Needham analysts predict Enovis's new products, orthopedic market strength, and the Lima acquisition will exceed 2024 consensus. They also foresee Paragon 28 returning to roughly 20% revenue growth in 2024 due to new bunion-focused products, supply chain enhancements, and sales force growth.

Needham Sees Orthopedics Market Slowing; Favors Enovis, Paragon 28

Moomoo AI

2023/12/05 19:10

Enovis CEO Matt Trerotola praised Shirley, Vogt, and Ross for their roles in the company's growth. He highlighted Shirley's influence on Enovis's transformation to a medtech firm, Vogt's contribution to the U.S. surgical business growth, and Ross's work in ensuring sustained growth in the P&R segment.

Press Release: Enovis Announces Business Segment Leadership Transition Plan

Moomoo AI

2023/11/30 21:01

Enovis' falling revenue and absent profits might have led to a drop in share price. Viewing the total shareholder return and recent share price rise, the company may suggest investment potential if it shows sustainable long term growth.

Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago

Moomoo AI

2023/11/03 22:26

Enovis's rise in liabilities and recent EBIT loss spark concerns about its debt use and future profitability. With a negative free cash flow of US$106m over the past year, the company's financial risk is evident. Balance sheet situation calls for caution due to dubious circumstances.

Would Enovis (NYSE:ENOV) Be Better Off With Less Debt?

Analysts Notebook

2023/06/26 20:11

專欄US Top Rating Updates on 6/26: MRNA, GOOG, TSLA, TXRH and More

$芝樂坊餐館(CAKE.US)$ initiated at equal-weight by Wells Fargo, announced target price at $33.00.
$德州公路酒吧(TXRH.US)$ initiated at equal-weight by Wells Fargo, announced targe price at $113.00.
$Moderna(MRNA.US)$ was upgraded by UBS from neutral to buy, but decreased target price from $221.00 to $191.00.
$Sotera Health Company(SHC.US)$ was upgraded by Keybanc from neutral to buy, announced target price at $24.00.
$谷歌-C(GOOG.US)$ was downg...

Analysts Notebook

2023/05/12 21:30

專欄US Top Rating Updates on 5/12: EA, DIS, TWLO, FOXA and More

$迪士尼(DIS.US)$Cut to Peer Perform From Outperform by Wolfe Research.
Disney Cut to Peer Perform From Outperform by Wolfe Research.
$Twilio(TWLO.US)$Cut to Neutral From Buy by Mizuho
Twilio shares slipped around 1% in pre-market trading on Friday after investment firm Mizuho downgraded the communications software company, citing "near-term" challenges.
$藝電(EA.US)$Raised to Buy From Hold by DZ Bank
DZ Bank analyst Markus...

逍遥投资派

2023/02/05 20:27

$Enovis Corp(ENOV.US)$營收4年來先降後升，整體微增，營業利潤也是先降後升，但是沒恢復到2018年水平，淨利潤則由於高昂的利息費用和其他淨損益影響，2019年大幅虧損2.5億，2020和2021年分別盈利0.46億和0.76億。
2022前3季度營收下滑59%，營業利潤繼續虧損，淨利潤則由於0.86億的其他淨收入和所得稅返還而盈利0.25億。
目前市盈率47，市盈率TTM已經提高到了172，加上核心盈利能力繼續惡化，目前沒有吸引力。

已翻譯

Analysts Notebook

2022/06/16 19:30

專欄Top upgrades and downgrades on 6/16: BA, DG, U, WSO and more

Upgrades
• $阿卡迪亞(ACAD.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $22)
• $亞瑟加拉格爾(AJG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182)
• $Apple Hospitality REIT(APLE.US)$ : B.Riley Upgrades to Buy from Neutral - PT $19
• $汽車地帶(AZO.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125)
• $波音(BA.US)$ : Citigroup Upgr...

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度